Home Medicine Relationship between PD-L1 expression and clinical characteristics in patients with breast invasive ductal carcinoma
Article Open Access

Relationship between PD-L1 expression and clinical characteristics in patients with breast invasive ductal carcinoma

  • Jian Lou , Yuefen Zhou , Jianhui Huang and Xiaojun Qian EMAIL logo
Published/Copyright: September 6, 2017
Download Article (PDF)
Open Medicine
From the journal Open Medicine Volume 12 Issue 1

Abstract

Objective

To evaluate the expression of PD-L1 (programmed death 1 ligand 1, PD-L1) and its clinical significance in breast invasive ductal carcinoma.

Methods

Tumor samples were collected from 64 cases of breast invasive ductal carcinoma patients, and tumor adjacent normal breast tissue were obtained as normal control. The expression of PD-L1 were examined by immunohistochemical staining and real time PCR assay, its correlations with patients’ clinical pathological characteristics were analyzed.

Results

PD-L1 was found to be over-expressed in 24 of 64 (37.5%) breast invasive ductal carcinoma samples, while in 1 of 22 (4.5%) tumor adjacent normal breast tissue which indicated PD-L1 was higher expressed in breast invasive ductal carcinoma samples than the tumor adjacent normal breast tissue (P < 0.05). PD-L1 positive expression was associated with clinical pathological characteristics of TNM stage and pathology grading (P < 0.05). However, PD-L1 positive expression was not correlated with age (P > 0.05), menstruation status (P >0.05), family history of breast cancer (P > 0.05), tumor diameter (P > 0.05), lymph node metastasis (P > 0.05) and tumor location (P > 0.05).

Conclusion

PD-L1 may play an important role in invasive ductal carcinoma, which could be a potential indicator for advanced clinical stage and poor prognosis.

Keywords: Programmed death 1 ligand 1; Breast invasive ductal carcinoma; Clinical characteristics

1 Introduction

Breast cancer is one of leading cause of cancer related death worldwide [1]. In western countries, most breast cancer cases can be diagnosed at an early stage given the availability of technology for early detection [2]. However, more than 40% of breast cancer cases admitted to hospitals in developing countries are at advanced stages [3]. Although effective chemotherapy, endocrine therapy, and trastuzumab-targeted therapy have been used in the clinical treatment of breast cancer, metastasis disease is still not cured. One-third of patients with advanced breast cancer eventually experience metastases and death [4]. Therefore, the early diagnosis and treatment of breast cancer is essential to its prognosis.

Programmed death ligand 1 (PD-L1), an immunoglobulin superfamily haplotype I transmembrane glycoprotein associated with apoptosis, binds to the programmed cell death-1 (PD-1) receptor [5]. It has been reported that PD-L1 expression is up regulated in human tumor cell lines of ovarian cancer, lymphoma, and etc, suggesting that it has a close relationship with tumorigenesis and development [6]. Numerous studies focused on PD-L1 expression in various malignant carcinomas, such as laryngeal cancer, colon cancer, and lung cancer. However, few studies on PD-L1 expression in breast cancer tissue have been conducted. This study aims to investigate PD-L1 expression in breast cancer by immunohistochemical staining and quantitative real-time PCR assay, which are commonly used in clinical pathology laboratory. And further discussion about the association between PD-L1 expression and clinical pathological characteristics in breast invasive ductal carcinoma patients was necessary.

2 Materials and methods

2.1 Patients

This study collected 64 cases of paraffin-embedded tissue specimens of breast invasive ductal carcinoma. All specimens were from patients with complete medical records in the pathology department of Lishui central hospital and who were admitted from February 2013 to March 2015. The patients inclusion criteria were: The patients were diagnosed with invasive ductal carcinoma with pathology confirmation; The patients had relative complete medical records; The patients did not received any preoperative chemoradiation or biotherapy; Written informed consents were obtained from all of the patients for their samples. The histological type of all cases was invasive ductal carcinoma. Moreover, 22 cases of normal peritumorial breast tissues (normal breast tissue taken from over 5 cm away from the edge of the breast tumor) were also collected. All the cases were female and did not receive radiotherapy or chemotherapy prior to surgery. The clinical data was complete. There were 28 cases with tumor diameters < 2 cm and 36 cases with tumor diameters ≥ 2 cm. Histopathological grading of tissue samples showed 18 cases of grade I tumors and 46 cases of grades II or III tumors. Tumor staging in accordance with the criteria of TNM staging of breast cancer by AJCC (2002) revealed that there were 42 cases in stages I or II and 22 cases in stage III.

Ethical approval: The research related to human use has been complied with all the relevant national regulations, institutional policies and in accordance the tenets of the Helsinki Declaration, and has been approved by the authors’ institutional review board or equivalent committee.

2.2 Immunohistochemistry assay

Paraffin-embedded specimens were cut into 4-μm sections. After dewaxing, dehydration in benzene, and hydration, the sections were stained by the streptavidin-peroxidase immunohistochemical method (SP method). The specific steps were described in the kit’s instruction manual. PD-L1 protein expression was detected for all specimens. A positive control was established for each staining. PBS was used as a negative control instead of a primary antibody.

2.3 Real-time quantitative PCR

RNA was extracted from the specimen with the following steps: dewaxing, tissue crushing, stratification, sedimentation, drying, and dissolution. The specific steps were performed according to the manufacturer’s instructions. Total RNA purity and concentration were determined by ultraviolet spectrophotometry photometer. Reverse transcription process was performed in accordance with the manufacturer’s instructions. The Ct value of the measured gene was corrected as follows: the Ct value of the internal reference gene GAPDH was subtracted from the Ct value of the target gene PD-L1 to represent the relative copy number of the gene to be measured: ΔCt = CtPLD-L1 - CtGAPDH. The average of each group ΔCt was then calculated.

2.4 PD-L1 positive and negative expression criteria

PD-L1 presents a positive color of yellow to brown particles in the cytoplasm. PD-L1 expression was assessed with semi-quantitative integration by combining the percentage of staining intensity and positive cells (immunohistochemical scores, IHS), IHS = a × b [7], where a represents the staining intensity and b represents the percentage of positive cells. The whole field of view of the section was first observed at low magnification. Then, five high power fields (×400) were randomly selected to view cancer cells and cancer stroma. The grading for “a” was as follows: 0 = no coloring, 1 point = light yellow, 2 points = brown yellow and 3 points = dark brown. The grading for “b” was as follows: 1 point = ≤10%, 2 points = 10%–50%, 3 points = >50%. When the two scores were multiplied, a result of ≥ 3 points indicated positive expression.

2.5 Statistical analysis

Analysis was conducted by SPSS 18.0 statistical software. PD-L1 expression and its relationship with clinicopathological features of breast cancer patients were analyzed by χ2 test. qRT-PCR results were analyzed by t test, where P<0.05 signified a statistically significant difference.

3 Results

3.1 Expression of PD-L1 in breast invasive ductal carcinoma and normal tissues

Immunohistochemical staining results showed that PD-L1 protein was highly expressed in invasive ductal carcinoma tissues with the positive rate of 37.5% (24/64). PD-L1 proteins were mainly located in the cytoplasm of cancer cells and cancer stromal lymphocytes (Figure 1). The 22 cases of peritumorial breast tissues lowly expressed PD-L1 protein at a positive rate of 4.5% (1/22). The difference between invasive ductal carcinoma and normal tissue was statistically different (P< 0.05).

Figure 1 PD-L1 expression in breast cancer tissues and normal peritumorial tissues. (A: PD-L1 negatively expressed in normal breast tissues; B: PD-L1 lowly expressed in infiltrating ductal carcinoma tissues; C: PD-L1 highly expressed in infiltrating ductal carcinoma tissues) ×20.
Figure 1

PD-L1 expression in breast cancer tissues and normal peritumorial tissues. (A: PD-L1 negatively expressed in normal breast tissues; B: PD-L1 lowly expressed in infiltrating ductal carcinoma tissues; C: PD-L1 highly expressed in infiltrating ductal carcinoma tissues) ×20.

3.2 Expression of PD-L1 and clinicopathological features of patients

PD-L1 expression was not significantly correlated with age, menopause history, family history, tumor size, lymph node metastasis, and tumor location (Pall>0.05). However, PD-L1 expression was correlated with clinical stage (P<0.05) and histopathological tumor grade (P<0.05), as shown in Table 1.

Table 1

PD-L1 expression and clinical characteristics of patients with breast invasive ductal carcinoma [n(%)]

Clinical characteristicsn=64Positive(n=24)Negative (n=40)Chi-squareP
Age0.400.52
 <55196(31.6)13(68.4)
 ≥554518(40.0)27(60.0)
Tumor location0.050.82
 Upper outer quadrant5822(37.9%)36(62.1)
 Others62(33.3)4(66.7)
Menopause0.010.93
 No114 (36.4)7 (63.6)
 Yes53 20 (37.7) 33 (62.3)
Tumor diameter0.070.79
 <22810(35.7)18(64.3)
 ≥23614(38.9)22(61.1)
Lymph node metastasis0.020.90
 Yes3011(36.7)19(63.3)0.29
 No3413(38.2)21(61.8)
Clinical stage5.330.02
 I – II4220 (47.6)22 (52.4)
 III224 (18.2)18 (81.8)
Pathology grading4.640.03
 I – II183(16.7)15(83.3)
 II – III4621 (45.7)25(54.3)
Breast cancer family history0.280.59
 Yes41(25.0)3(75.0)
 No6023(38.3)37(61.7)

3.3 Expression of PD-L1 mRNA ininvasive ductal carcinoma

Real-time quantitative PCR results showed that PD-L1 was highly expressed in breast invasive ductal carcinoma with an average ΔCt of 7.45±1.82. PD-L1 was lowly expressed in normal peritumorial breast tissues with an average ΔCt of 14.17±3.53. The difference of PD-L1 mRNA expression was statistically different (P<0.05), Figure 2.

Figure 2 Expression of PD-L1 mRNA in cancer tissue and peritumorial tissue
Figure 2

Expression of PD-L1 mRNA in cancer tissue and peritumorial tissue

4 Discussion

Several studies [8, 9] have investigated PD-L1 expression in breast cancer specimens via immunohistochemical methods and found that PD-L1 expression is correlated with ER-negative, PR-negative and histopathological grade III in patients of breast cancer. Studies on breast cancer with lymph node metastasis found that PD-L1 expression is positively correlated with a large lymph node volume and tumors that express positive human epidermal growth factor receptor 2 (HER2) [10,11]. Moreover, our study showed that PD-L1 was highly expressed in invasive ductal carcinoma tissues and that PD-L1 was positively correlated with clinical stages and histopathological tumor grade. In a tumor-bearing mouse model, treatment with anti-PD-L1 monoclonal antibodies significantly inhibited tumor growth and cleared tumor cells; some cases even showed complete remission [12]. Compared with the single treatment of cytotoxic T lymphocyte therapy, the combined use of cytotoxic T lymphocytes can effectively improve the survival rate of tumor-bearing mice [13]. Therefore, the PD-1/PD-L1 pathway may be involved in the recurrence and metastasis of breast cancer subtypes, such as triple negative (with negative ER, PR, and HER2 expression) breast cancer [8].

Chemotherapy is generally used clinically to inhibit cancer cells proliferation, invasion, and metastasis. Breast cancer is commonly treated with anthracycline chemotherapy drugs. Studies have shown that adriamycin reduces PD-L1 expression on the surface of breast cancer cells, promotes the specific killing of tumor cells by T cells, and inhibits the binding of PD-L1 and PD-1 on the T-cell surface [14]. Studies have proved that although adriamycin effectively reduces PD-L1 expression on the surface of breast cancer cells, PD-L1 expression is up-regulated in the nuclei of breast cancer cells[8, 15]. PD-L1 promotes the nuclear migration of PD-L1 on the tumor cell membrane to increase PD-L1 expression in the cell nucleus; this mechanism is a self-protective mechanism of tumor cells to prevent apoptosis during cancer chemotherapy[16]. Nimesulide selectively inhibits scyclooxygenase II and induces PD-L1 expression on the surface of breast cancer cells through interferons, thereby promoting the apoptosis of cancer cells while simultaneously inhibiting metastasis and progression [17]. However, given that chemotherapy drugs are not highly selective, chemotherapy will inevitably damage the body’s normal cells, resulting in adverse drug reactions. CD8+ T-cell can inhibit PD-L1 expression on the surfaces of tumor cells and promote the apoptosis of tumor cells. CD8+T-cell can be activated by transfecting the costimulatory molecule CD80 in human tumor cell lines via RNA interference technology. Therefore, CD80 is a potential drug target for anti-tumor therapy. Using costimulatory molecules as therapeutic drugs can not only facilitate targeted tumor treatment, but also reduce the adverse reactions caused by traditional chemotherapy drugs [18].

In our present study, we found that PD-L1 positive expression was associated with clinical pathological characteristics of TNM stage and pathology grading, which indicated that PD-L1 may play an important role in invasive ductal carcinoma of breast cancer patients. However, because of small sample size and short term follow-up period, the correlation between PD-L1 expression and prognosis of breast cancer patients was not evaluated. So, more patients and long term follow-up are need for further evaluation PD-L1 expression and patients’s survival.

In recent years, the wide clinical applications of radiotherapy, chemotherapy, and medical therapy have significantly improved the prognosis of breast cancer patients. However, triple-negative breast cancer and metastatic breast cancer are still difficult to management. The detection of PD-L1 can provide guidance for the selection of appropriate chemotherapeutic drugs. PD-L1 can also be used as an independent factor to determine prognosis, and specific anti-PD-L1 monoclonal antibodies are novel concepts to consider in the immune therapy of breast cancer.

Tel:+86575-88229462

  1. Conflict of interest

    Conflict of interest statement: Authors state no conflict of interest.

References

[1] DeSantis C, Siegel R, Bandi P, et al. Breast cancer statistics, 2011[J]. CA Cancer J Clin, 2011,61(6):409-41810.3322/caac.20134Search in Google Scholar PubMed

[2] Cianfrocca M, Goldstein LJ. Prognostic and predictive factors in early-stage breast cancer[J]. Oncologist, 2004,9(6):606-61610.1634/theoncologist.9-6-606Search in Google Scholar PubMed

[3] Ezzat AA, Ibrahim EM, Raja MA, et al. Locally advanced breast cancer in Saudi Arabia: high frequency of stage III in a young population[J]. Medical oncology (Northwood, London, England), 1999,16(2):95-10310.1007/BF02785842Search in Google Scholar PubMed

[4] Newman LA. Epidemiology of locally advanced breast cancer[J]. Semin Radiat Oncol, 2009,19(4):195-20310.1016/j.semradonc.2009.05.003Search in Google Scholar PubMed

[5] Gianchecchi E, Delfino DV, Fierabracci A. Recent insights into the role of the PD-1/PD-L1 pathway in immunological tolerance and autoimmunity[J]. Autoimmun Rev, 2013,12(11):1091-110010.1016/j.autrev.2013.05.003Search in Google Scholar PubMed

[6] Pedoeem A, Azoulay-Alfaguter I, Strazza M, et al. Programmed death-1 pathway in cancer and autoimmunity[J]. Clinical immunology (Orlando, Fla.), 2014,153(1):145-15210.1016/j.clim.2014.04.010Search in Google Scholar PubMed

[7] Mu CY, Huang JA, Chen Y, et al. High expression of PD-L1 lung cancer may contribute to poor prognosis and tumor cells immune escape through suppressing tumor infiltr; dendritic cells maturation[J]. Medical oncology (Northwood, London, England), 2011,28(3):682-68810.1007/s12032-010-9515-2Search in Google Scholar PubMed

[8] Mittendorf EA, Philips AV, Meric-Bernstam F, et al. PD-L1 expression in triple-negative breast cancer[J]. Cancer Immunol Res, 2014,2(4):361-37010.1158/2326-6066.CIR-13-0127Search in Google Scholar PubMed PubMed Central

[9] Soliman H, Khalil F, Antonia S. PD-L1 expression is increased in a subset of basal type breast cancer cells[J]. PLoS One, 2014,9(2):e8855710.1371/journal.pone.0088557Search in Google Scholar PubMed PubMed Central

[10] Janakiram M, Abadi YM, Sparano JA, et al. T cell coinhibition and immunotherapy in human breast cancer[J]. Discov Med, 2012,14(77):229-236Search in Google Scholar

[11] Sendur MA, Aksoy S, Demirci S, et al. Can targeted programmed death-1 antibody be a new treatment approach in breast cancer[J]. J BUON, 2014,19(2):584Search in Google Scholar

[12] Wang J, Jensen M, Lin Y, et al. Optimizing adoptive polyclonal T cell immunotherapy of lymphomas, using a chimeric T cell receptor possessing CD28 and CD137 costimulatory domains[J]. Hum Gene Ther, 2007,18(8):712-72510.1089/hum.2007.028Search in Google Scholar PubMed

[13] Charo J, Finkelstein SE, Grewal N, et al. Bcl-2 overexpression: enhances tumor-specific T-cell survival[J]. Cancer Res, 2005,65(5):2001-200810.1158/0008-5472.CAN-04-2006Search in Google Scholar PubMed PubMed Central

[14] Hasan A, Ghebeh H, Lehe C, et al. Therapeutic targeting of B7-H1 in breast cancer[J]. Expert Opin Ther Targets, 2011,15(10):1211-122510.1517/14728222.2011.613826Search in Google Scholar PubMed

[15] Muenst S, Schaerli AR, Gao F, et al. Expression of programmed death ligand 1 (PD-L1) is associated with poor prognosis in human breast cancer[J]. Breast Cancer Res Treat, 2014,146(1):15-24. [10.1007/s10549-014-2988-5Search in Google Scholar PubMed PubMed Central

[16] Ghebeh H, Lehe C, Barhoush E, et al. Doxorubicin downregulates cell surface B7-H1 expression and upregulates its nuclear expression in breast cancer cells: role of B7-H1 as an anti-apoptotic molecule[J]. Breast Cancer Res, 2010,12(4):R4810.1186/bcr2605Search in Google Scholar PubMed PubMed Central

[17] Liang M, Yang H, Fu J. Nimesulide inhibits IFN-gamma-induced programmed death-1-ligand 1 surface expression in breast cancer cells by COX-2 and PGE2 independent mechanisms[J]. Cancer Lett, 2009,276(1):47-5210.1016/j.canlet.2008.10.028Search in Google Scholar PubMed

[18] Haile ST, Bosch JJ, Agu NI, et al. Tumor cell programmed death ligand 1-mediated T cell suppression is overcome by coexpression of CD80[J]. Journal of immunology (Baltimore, Md.: 1950), 2011,186(12):6822-682910.4049/jimmunol.1003682Search in Google Scholar PubMed PubMed Central

Received: 2016-11-17
Accepted: 2017-4-6
Published Online: 2017-9-6

© 2017 Jian Lou et al.

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Articles in the same Issue

  1. Regular Articles
  2. Intravascular treatment of left subclavian artery aneurysm coexisting with aortic coarctation in an adult patient
  3. Regular Articles
  4. Effect of electrical stimulation on blood flow velocity and vessel size
  5. Regular Articles
  6. Live birth pregnancy outcome after first in vitro fertilization treatment in a patient with Systemic Lupus Erythematosus and isolated high positive IgA anti-β2glycoprotein I antibodies: a case report
  7. Regular Articles
  8. Periodontal ligament stem cells regulate apoptosis of neutrophils
  9. Regular Articles
  10. Platelet-rich fibrin (PRF) in implants dentistry in combination with new bone regenerative flapless technique: evolution of the technique and final results
  11. Regular Articles
  12. The significance of strong ion gap for predicting return of spontaneous circulation in patients with cardiopulmonary arrest
  13. Regular Articles
  14. Clinicopathology of EpCAM and EGFR in human epithelial ovarian carcinoma
  15. Regular Articles
  16. Intraosseous lipoma of the mandibula: A case report and review of the literature
  17. Regular Articles
  18. Transurethral resection of the prostate, bladder explosion and hyponatremic encephalopathy: a rare case report of malpractice
  19. Regular Articles
  20. Brain strokes related to aortic aneurysma – the analysis of three cases
  21. Regular Articles
  22. Effect of Bicyclol tablets on drug induced liver injuries after kidney transplantation
  23. Regular Articles
  24. Plasma free fatty acids in hyperemesis gravidarum pregnancy
  25. Regular Articles
  26. Impact of chromosomal rearrangement upon DNA methylation patterns in leukemia
  27. Regular Articles
  28. Gefitinib versus docetaxel in treated non-small-cell lung cancer: a meta-analysis
  29. Regular Articles
  30. The clinical characteristics of patients with chronic idiopathic anal pain
  31. Regular Articles
  32. Bone tunnel impaction reduced the tibial tunnel enlargement
  33. Regular Articles
  34. Effects of S-1 combined with radiotherapy in the treatment of nasopharyngeal cancer: a meta-analysis based on randomized controlled trials
  35. Regular Articles
  36. Predictions and outcomes of atrial fibrillation in the patients with acute myocardial infarction
  37. Regular Articles
  38. An accuracy study of the Intracavitary Electrocardiogram (IC-ECG) guided peripherally inserted central catheter tip placement among neonates
  39. Regular Articles
  40. Serum CA125, CA199 and CEA combined detection for epithelial ovarian cancer diagnosis: A meta-analysis
  41. Regular Articles
  42. Surface coil intensity correction in magnetic resonance imaging in spinal metastases
  43. Regular Articles
  44. Muscle stem cell and physical activity: what point is the debate at?
  45. Regular Articles
  46. MicroRNA let-7g directly targets forkhead box C2 (FOXC2) to modulate bone metastasis in breast cancer
  47. Regular Articles
  48. Monitoring health inequalities at the municipal level: Lithuanian experience
  49. Regular Articles
  50. Role of Epstein-Barr virus in the development of nasopharyngeal carcinoma
  51. Regular Articles
  52. Thrombectomy combined with indwelling-catheter thrombolysis is more effective than pure thrombectomy for the treatment of lower extremity deep venous thrombosis
  53. Regular Articles
  54. Expression of Hepcidin and Neogenin in colorectal cancer
  55. Regular Articles
  56. Carnitine and adiponectin levels in breast cancer after radiotherapy
  57. Regular Articles
  58. Pathophysiology of meningioma growth in pregnancy
  59. Regular Articles
  60. Causal neuro-immune relationships at patients with chronic pyelonephritis and cholecystitis. Correlations between parameters EEG, HRV and white blood cell count
  61. Regular Articles
  62. Measuring efficiency of secondary healthcare providers in Slovenia
  63. Regular Articles
  64. Galectin-3 expression in colorectal cancer and its correlation with clinical pathological characteristics and prognosis
  65. Regular Articles
  66. Model for studying anti- allergic drugs for allergic conjunctivitis in animals
  67. Regular Articles
  68. Barriers perceived by nurses in the optimal treatment of postoperative pain
  69. Regular Articles
  70. Tumor microenvironment in treatment of glioma
  71. Regular Articles
  72. Delirium risk of dexmedetomidine and midazolam in patients treated with postoperative mechanical ventilation: A meta-analysis
  73. Regular Articles
  74. Hemangioma of the rib: a rare case report and literature review
  75. Regular Articles
  76. The diagnostic accuracy of conventional forceps biopsy compared to ESD
  77. Regular Articles
  78. Increased miR-25 expression in serum of gastric cancer patients is correlated with CA19-9 and acts as a potential diagnostic biomarker
  79. Regular Articles
  80. Therapeutic nanomedicine surmounts the limitations of pharmacotherapy
  81. Regular Articles
  82. Relationship between PD-L1 expression and clinical characteristics in patients with breast invasive ductal carcinoma
  83. Regular Articles
  84. Trypsinogen activation peptide induces HMGB1 release from rat pancreatic acinar cells
  85. Regular Articles
  86. The effective regulation of pro- and anti-inflammatory cytokines induced by combination of PA-MSHA and BPIFB1 in initiation of innate immune responses
  87. Regular Articles
  88. Cell based therapeutic approach in vascular surgery: application and review
  89. Regular Articles
  90. Clinical efficacy of alprostadil combined with α-lipoic acid in the treatment of elderly patients with diabetic nephropathy
  91. Regular Articles
  92. Professional burnout and concurrent health complaints in neonatal nursing
  93. Regular Articles
  94. Esophageal xanthoma: presence of M2 macrophages suggests association with late inflammatory and reparative processes
  95. Regular Articles
  96. Cone beam computed tomography analysis in 3D position of maxillary denture
  97. Regular Articles
  98. CK20 mRNA expression in serum as a biomarker for colorectal cancer diagnosis: A meta-analysis
  99. Regular Articles
  100. Serum AFU, 5’-NT and AFP as biomarkers for primary hepatocellular carcinoma diagnosis
  101. Regular Articles
  102. Absolute reliability and concurrent validity of hand held dynamometry and isokinetic dynamometry in the hip, knee and ankle joint: systematic review and meta-analysis
  103. Regular Articles
  104. The Fountain of Youth: A tale of parabiosis, stem cells, and rejuvenation
  105. Regular Articles
  106. Foam sclerotherapy during shunt surgery for portal hypertension and varices
  107. Regular Articles
  108. Insomnia and depression: Japanese hospital workers questionnaire survey
  109. Regular Articles
  110. Serum NF-κBp65, TLR4 as biomarker for diagnosis of preeclampsia
  111. Regular Articles
  112. Docetaxel/cisplatin therapy in myasthenia gravis with hypertension/diabetes
  113. Regular Articles
  114. Fluid resuscitation and markers of glycocalyx degradation in severe sepsis
  115. Regular Articles
  116. Modified Sauve-Kapandji procedure for patients with old fractures of the distal radius
  117. Regular Articles
  118. Bile leakage after liver transplantation
  119. Regular Articles
  120. VEGF overexpression predicts poor survival in hepatocellular carcinoma
  121. Regular Articles
  122. Galen vein aneurysm– challenge for treatment
  123. Regular Articles
  124. Retrieval of a broken sewing needle from the sacrum aided by a permanent magnet: a case report and literature review
  125. Regular Articles
  126. HIV/STI prevention interventions: A systematic review and meta-analysis
  127. Regular Articles
  128. Aortic aneurysm as a complication of myeloperoxidase-antineutrophil cytoplasmic antibody-associated vasculitis
  129. Regular Articles
  130. Real-time monitoring of contrast-enhanced ultrasound for radio frequency ablation
  131. Regular Articles
  132. Successful drug-eluting stent implantation in a male patient with dextrocardia: a case report
  133. Regular Articles
  134. Primary pleomorphic liposarcoma of fallopian tube with recurrence: a case report and review of the literature
  135. Regular Articles
  136. Color Doppler Ultrasound in Uterine Arterial Embolization
  137. Regular Articles
  138. Pattern of alcohol consumption by young people from North Eastern Portugal
  139. Regular Articles
  140. Effects of out-of-hospital continuing nursing on schizophrenia patients' rehabilitation and quality of life
https://doi.org/10.1515/med-2017-0042
Keywords for this article
Programmed death 1 ligand 1; Breast invasive ductal carcinoma; Clinical characteristics
Creative Commons
BY-NC-ND 3.0

Articles in the same Issue

  1. Regular Articles
  2. Intravascular treatment of left subclavian artery aneurysm coexisting with aortic coarctation in an adult patient
  3. Regular Articles
  4. Effect of electrical stimulation on blood flow velocity and vessel size
  5. Regular Articles
  6. Live birth pregnancy outcome after first in vitro fertilization treatment in a patient with Systemic Lupus Erythematosus and isolated high positive IgA anti-β2glycoprotein I antibodies: a case report
  7. Regular Articles
  8. Periodontal ligament stem cells regulate apoptosis of neutrophils
  9. Regular Articles
  10. Platelet-rich fibrin (PRF) in implants dentistry in combination with new bone regenerative flapless technique: evolution of the technique and final results
  11. Regular Articles
  12. The significance of strong ion gap for predicting return of spontaneous circulation in patients with cardiopulmonary arrest
  13. Regular Articles
  14. Clinicopathology of EpCAM and EGFR in human epithelial ovarian carcinoma
  15. Regular Articles
  16. Intraosseous lipoma of the mandibula: A case report and review of the literature
  17. Regular Articles
  18. Transurethral resection of the prostate, bladder explosion and hyponatremic encephalopathy: a rare case report of malpractice
  19. Regular Articles
  20. Brain strokes related to aortic aneurysma – the analysis of three cases
  21. Regular Articles
  22. Effect of Bicyclol tablets on drug induced liver injuries after kidney transplantation
  23. Regular Articles
  24. Plasma free fatty acids in hyperemesis gravidarum pregnancy
  25. Regular Articles
  26. Impact of chromosomal rearrangement upon DNA methylation patterns in leukemia
  27. Regular Articles
  28. Gefitinib versus docetaxel in treated non-small-cell lung cancer: a meta-analysis
  29. Regular Articles
  30. The clinical characteristics of patients with chronic idiopathic anal pain
  31. Regular Articles
  32. Bone tunnel impaction reduced the tibial tunnel enlargement
  33. Regular Articles
  34. Effects of S-1 combined with radiotherapy in the treatment of nasopharyngeal cancer: a meta-analysis based on randomized controlled trials
  35. Regular Articles
  36. Predictions and outcomes of atrial fibrillation in the patients with acute myocardial infarction
  37. Regular Articles
  38. An accuracy study of the Intracavitary Electrocardiogram (IC-ECG) guided peripherally inserted central catheter tip placement among neonates
  39. Regular Articles
  40. Serum CA125, CA199 and CEA combined detection for epithelial ovarian cancer diagnosis: A meta-analysis
  41. Regular Articles
  42. Surface coil intensity correction in magnetic resonance imaging in spinal metastases
  43. Regular Articles
  44. Muscle stem cell and physical activity: what point is the debate at?
  45. Regular Articles
  46. MicroRNA let-7g directly targets forkhead box C2 (FOXC2) to modulate bone metastasis in breast cancer
  47. Regular Articles
  48. Monitoring health inequalities at the municipal level: Lithuanian experience
  49. Regular Articles
  50. Role of Epstein-Barr virus in the development of nasopharyngeal carcinoma
  51. Regular Articles
  52. Thrombectomy combined with indwelling-catheter thrombolysis is more effective than pure thrombectomy for the treatment of lower extremity deep venous thrombosis
  53. Regular Articles
  54. Expression of Hepcidin and Neogenin in colorectal cancer
  55. Regular Articles
  56. Carnitine and adiponectin levels in breast cancer after radiotherapy
  57. Regular Articles
  58. Pathophysiology of meningioma growth in pregnancy
  59. Regular Articles
  60. Causal neuro-immune relationships at patients with chronic pyelonephritis and cholecystitis. Correlations between parameters EEG, HRV and white blood cell count
  61. Regular Articles
  62. Measuring efficiency of secondary healthcare providers in Slovenia
  63. Regular Articles
  64. Galectin-3 expression in colorectal cancer and its correlation with clinical pathological characteristics and prognosis
  65. Regular Articles
  66. Model for studying anti- allergic drugs for allergic conjunctivitis in animals
  67. Regular Articles
  68. Barriers perceived by nurses in the optimal treatment of postoperative pain
  69. Regular Articles
  70. Tumor microenvironment in treatment of glioma
  71. Regular Articles
  72. Delirium risk of dexmedetomidine and midazolam in patients treated with postoperative mechanical ventilation: A meta-analysis
  73. Regular Articles
  74. Hemangioma of the rib: a rare case report and literature review
  75. Regular Articles
  76. The diagnostic accuracy of conventional forceps biopsy compared to ESD
  77. Regular Articles
  78. Increased miR-25 expression in serum of gastric cancer patients is correlated with CA19-9 and acts as a potential diagnostic biomarker
  79. Regular Articles
  80. Therapeutic nanomedicine surmounts the limitations of pharmacotherapy
  81. Regular Articles
  82. Relationship between PD-L1 expression and clinical characteristics in patients with breast invasive ductal carcinoma
  83. Regular Articles
  84. Trypsinogen activation peptide induces HMGB1 release from rat pancreatic acinar cells
  85. Regular Articles
  86. The effective regulation of pro- and anti-inflammatory cytokines induced by combination of PA-MSHA and BPIFB1 in initiation of innate immune responses
  87. Regular Articles
  88. Cell based therapeutic approach in vascular surgery: application and review
  89. Regular Articles
  90. Clinical efficacy of alprostadil combined with α-lipoic acid in the treatment of elderly patients with diabetic nephropathy
  91. Regular Articles
  92. Professional burnout and concurrent health complaints in neonatal nursing
  93. Regular Articles
  94. Esophageal xanthoma: presence of M2 macrophages suggests association with late inflammatory and reparative processes
  95. Regular Articles
  96. Cone beam computed tomography analysis in 3D position of maxillary denture
  97. Regular Articles
  98. CK20 mRNA expression in serum as a biomarker for colorectal cancer diagnosis: A meta-analysis
  99. Regular Articles
  100. Serum AFU, 5’-NT and AFP as biomarkers for primary hepatocellular carcinoma diagnosis
  101. Regular Articles
  102. Absolute reliability and concurrent validity of hand held dynamometry and isokinetic dynamometry in the hip, knee and ankle joint: systematic review and meta-analysis
  103. Regular Articles
  104. The Fountain of Youth: A tale of parabiosis, stem cells, and rejuvenation
  105. Regular Articles
  106. Foam sclerotherapy during shunt surgery for portal hypertension and varices
  107. Regular Articles
  108. Insomnia and depression: Japanese hospital workers questionnaire survey
  109. Regular Articles
  110. Serum NF-κBp65, TLR4 as biomarker for diagnosis of preeclampsia
  111. Regular Articles
  112. Docetaxel/cisplatin therapy in myasthenia gravis with hypertension/diabetes
  113. Regular Articles
  114. Fluid resuscitation and markers of glycocalyx degradation in severe sepsis
  115. Regular Articles
  116. Modified Sauve-Kapandji procedure for patients with old fractures of the distal radius
  117. Regular Articles
  118. Bile leakage after liver transplantation
  119. Regular Articles
  120. VEGF overexpression predicts poor survival in hepatocellular carcinoma
  121. Regular Articles
  122. Galen vein aneurysm– challenge for treatment
  123. Regular Articles
  124. Retrieval of a broken sewing needle from the sacrum aided by a permanent magnet: a case report and literature review
  125. Regular Articles
  126. HIV/STI prevention interventions: A systematic review and meta-analysis
  127. Regular Articles
  128. Aortic aneurysm as a complication of myeloperoxidase-antineutrophil cytoplasmic antibody-associated vasculitis
  129. Regular Articles
  130. Real-time monitoring of contrast-enhanced ultrasound for radio frequency ablation
  131. Regular Articles
  132. Successful drug-eluting stent implantation in a male patient with dextrocardia: a case report
  133. Regular Articles
  134. Primary pleomorphic liposarcoma of fallopian tube with recurrence: a case report and review of the literature
  135. Regular Articles
  136. Color Doppler Ultrasound in Uterine Arterial Embolization
  137. Regular Articles
  138. Pattern of alcohol consumption by young people from North Eastern Portugal
  139. Regular Articles
  140. Effects of out-of-hospital continuing nursing on schizophrenia patients' rehabilitation and quality of life
Sign up now to receive a 20% welcome discount
Institutional Access
How does access work?
Have an idea on how to improve our website?
Please write us.
© 2026 De Gruyter Brill
Downloaded on 25.1.2026 from https://www.degruyterbrill.com/document/doi/10.1515/med-2017-0042/html
Scroll to top button